Netherlands Compounding Pharmacies Market | Coherent Market Insights - PowerPoint PPT Presentation

View by Category
About This Presentation

Netherlands Compounding Pharmacies Market | Coherent Market Insights


Read here the latest updates on the Netherlands Compounding Pharmacies Market published by the CMI team. – PowerPoint PPT presentation

Number of Views:11
Date added: 18 August 2020
Slides: 13
Provided by: adwaitcoherent


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Netherlands Compounding Pharmacies Market | Coherent Market Insights

Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//
  • Covid-19 Impact Tracker

  • Netherlands Compounding Pharmacies Market, By
    Product Type (Mouthwashes, Oral Medication
    (Capsule, Lollipops, Lozenges, Suspensions,Tablets
    ), Suppositories Topical Medication (Cream, Gels,
    Lotions, Ointments)), By Application (Medication
    for Adults, Medication for Children, Medication
    for Geriatric, Medication for Veterinary), By
    Therapeutic Area (Hormone Replacement Therapy,
    Pain Management), By Facilities (Community
    Pharmacies, Hospitals) - Size, Share, Outlook,
    and Opportunity Analysis, 2019 - 2027

  • Netherlands Compounding Pharmacies Market
  • Increasing prevalence of chronic diseases is
    expected to boost growth of the Netherlands
    compounding pharmacies market over the forecast
    period. For instance, according to Globocan 2018,
    119,923 cases of cancer were registered in the
  • Moreover, decreasing supply of essential drugs is
    also expected to propel growth of the market. For
    instance, according to Royal Dutch Society for
    the Promotion of Pharmacy (KNMP), 769 medicines
    were unavailable at some stage during 2018,
    including 128 treatments that were taken out of
    circulation altogether.
  • Oral medication held dominant position in the
    Netherlands compounding pharmacies market in
    2018, accounting for 62.9 share in terms of
    value, followed by topical medication.


  • Netherlands Compounding Pharmacies Market
  • However, a major factor hindering growth of the
    Netherlands compounding pharmacies market is
    adoption of unsafe compounding practices such as
    compounding contamination and non-adherence to
    GMP regulations.
  • Moreover, certain compounded drugs in the
    Netherlands have been associated with adverse
    drug reactions as they constitute drugs that are
    banned under pharmacovigilance measures. Adverse
    drug reactions prove detrimental to patients and
    related partys confidence in compounded drugs.
    For instance, clioquinola drug used for
    controlling amoebiasis and infections with
    dientamoeba fragilisis no longer registered
    through the Medicines Evaluation Board for
    systemic use in the Netherlands and is only
    available as a compounded drug. In 2015,
    according to Netherlands Pharmacovigilance
    Center, use of clioquinol in compounded form led
    to 33 reports concerning adverse drug reactions.

Netherlands Compounding Pharmacies Market
  • Increasing GMP compliance is expected to offer
    lucrative growth opportunities for players in the
    Netherlands compounding pharmacies market.
    Currently, inspection for adherence to GMP
    guidelines is only available for industrial
    manufacturing of drugs in the Netherlands.
    However, community compounding pharmacies need to
    adhere to best practice guidelines, as hospitals
    in the country are expected to outsource more
    drug compounding to the community compounding
  • Key players in the market can also focus on RD
    of products related to geriatric and long-term
    care and innovative Hormone replacement therapy
    (HRT) applications to expand their product

Market Trends/Key Takeaways
  • The market is witnessing increasing preference
    for HRT drugs for indications such as menopausal
    symptoms, mens health (andropause), and weight
    loss. However, untested ingredients, possibility
    of microbiological contaminations, errors in
    defining dosages of hormones and declining
    reimbursements from government are some of the
    factors that may hamper demand for HRT drugs in
    the Netherlands.
  • In the Netherlands, products are primarily
    purchased from specialized compounding companies
    and products from major market players are in
    high demand compared to those of community
    compounding pharmacies. Moreover, a majority of
    compounded drugs are outsourced to hospitals.

Netherlands Compounding Pharmacies Market Key
  • Key players in the market are focused on
    geographical expansion through MA activities.
    For instance, in May 2019, Fagron entered into an
    agreement to acquire Central de Drogas, S.A. de
    C.V., a leading supplier of raw materials to
    compounding pharmacies and the pharmaceutical
    industry in Mexico.
  • Key players in the market are also focused on
    product development to expand their product
    portfolio. For instance, in November 2018, AMC, a
    hospital in Amsterdam focused on producing
    compounding drugs, received permission from the
    Dutch Health and Youth Care Inspectorate to
    produce an equivalent of chenodeoxycholic acid
    (CDCA) if the used resources meet the quality

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email

Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//